These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 24014920

  • 21. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand.
    Hiransuthikul A, Rattananupong T, Klaewsongkram J, Rerknimitr P, Pongprutthipan M, Ruxrungtham K.
    Allergol Int; 2016 Oct; 65(4):432-438. PubMed ID: 27134114
    [Abstract] [Full Text] [Related]

  • 22. Sildenafil-induced drug reaction with eosinophilia and systemic symptoms.
    Chabbouh A, Rebhi F, Ben Slimene M, Jaber K, Dhaoui A.
    Urol Case Rep; 2024 Jul; 55():102789. PubMed ID: 39071852
    [Abstract] [Full Text] [Related]

  • 23. Leukemoid reaction in minocycline-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: A brief report.
    Shea M, Weese K, Dhossche J.
    Pediatr Dermatol; 2024 Jul; 41(1):141-142. PubMed ID: 37496096
    [Abstract] [Full Text] [Related]

  • 24. Stevens-Johnson syndrome in an HIV-infected patient.
    Blitz M, Spivack E, Kerpel SM, Freedman PD.
    AIDS Read; 1999 Jul; 9(3):184-5, 190. PubMed ID: 12728904
    [Abstract] [Full Text] [Related]

  • 25. Phenytoin-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report from the emergency department.
    Oelze LL, Pillow MT.
    J Emerg Med; 2013 Jan; 44(1):75-8. PubMed ID: 21852061
    [Abstract] [Full Text] [Related]

  • 26. Ceftriaxone induced drug rash with eosinophilia and systemic symptoms.
    Guleria VS, Dhillon M, Gill S, Naithani N.
    J Res Pharm Pract; 2014 Apr; 3(2):72-4. PubMed ID: 25114941
    [Abstract] [Full Text] [Related]

  • 27. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis.
    Wei BM, Fox LP, Kaffenberger BH, Korman AM, Micheletti RG, Mostaghimi A, Noe MH, Rosenbach M, Shinkai K, Kwah JH, Phillips EJ, Bolognia JL, Damsky W, Nelson CA.
    J Am Acad Dermatol; 2024 May; 90(5):885-908. PubMed ID: 37516359
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Bosentan-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
    Allanore Y, Moachon L, Maury E, Isvy A, Kahan A.
    J Rheumatol; 2010 May; 37(5):1077-8. PubMed ID: 20439535
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Rash and hepatitis within days of starting a new antiretroviral regimen: nevirapine hypersensitivity, secondary syphilis or both?
    Saxon CJ, Helbert MR, Komolafe AJ, Higgins SP.
    Int J STD AIDS; 2014 Mar; 25(3):228-30. PubMed ID: 23970648
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.